Genetic variants of FOXP3 influence graft survival in kidney transplant patients

Human Immunology

Volumn 74, Issue 6, 2013, Pages 751-757

  Engela, Anja U ^a   Boer, Karin ^a   Roodnat, Joke I ^a   Peeters, Annemiek M A ^a   Eilers, Paul H ^a   Kal van Gestel, Judith A ^a   Rivadeneira, Fernando ^a   Weimar, Willem ^a   Baan, Carla C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; DINUCLEOTIDE REPEATS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84877065467     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.02.008     Document Type: Article

References (47)

1. Gandolfo M.T., Jang H.R., Bagnasco S.M., Ko G.J., Agreda P., Satpute S.R., et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 2009 Oct, 76(7):717-729.
2. Kinsey G.R., Huang L., Vergis A.L., Li L., Okusa M.D. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 2010 May, 77(9):771-780.
3. Hendrikx T.K., van Gurp E.A., Sewgobind V.D., Mol W.M., Schoordijk W., Klepper M., et al. Generation of donor-specific regulatory T-cell function in kidney transplant patients. Transplantation 2009 Feb 15, 87(3):376-383.
4. Nadig S.N., Wieckiewicz J., Wu D.C., Warnecke G., Zhang W., Luo S., et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010 Jul, 16(7):809-813.
5. McMurchy A.N., Bushell A., Levings M.K., Wood K.J. Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 2011, 23(4):304-313.
6. Veronese F., Rotman S., Smith R.N., Pelle T.D., Farrell M.L., Kawai T., et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 2007 Apr, 7(4):914-922.
7. Geiger T.L., Tauro S. Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function. Hum Immunol 2012 Mar, 73(3):232-239.
8. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008 Mar, 9(3):239-244.
9. Tran D.Q., Shevach E.M. Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells. Hum Immunol 2009 May, 70(5):294-299.
10. + regulatory T cells. Nat Immunol 2003 Apr, 4(4):330-336.
11. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 Feb 14, 299(5609):1057-1061.
12. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., et al. A full genome search in multiple sclerosis. Nat Genet 1996 Aug, 13(4):472-476.
13. Cornelis F., Faure S., Martinez M., Prud'homme J.F., Fritz P., Dib C., et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998 Sep 1, 95(18):10746-10750.
14. Cucca F., Goy J.V., Kawaguchi Y., Esposito L., Merriman M.E., Wilson A.J., et al. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet 1998 Jul, 19(3):301-302.
15. Bassuny W.M., Ihara K., Sasaki Y., Kuromaru R., Kohno H., Matsuura N., et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003 Jun, 55(3):149-156.
16. http://www.r-project.org; The R Project for Statistical Computing; R Development Core Team, R Foundation for Statistical Computing; Vienna, Austria. Last accessed November 14th, 2012.
17. Sanchez E., Rueda B., Orozco G., Oliver J., Vilchez J.R., Paco L., et al. Analysis of a GT microsatellite in the promoter of the foxp3/scurfin gene in autoimmune diseases. Hum Immunol 2005 Aug, 66(8):869-873.
18. Clayton D. Testing for association on the X chromosome. Biostatistics 2008 Oct, 9(4):593-600.
19. Tommasini A., Ferrari S., Moratto D., Badolato R., Boniotto M., Pirulli D., et al. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin Exp Immunol 2002 Oct, 130(1):127-130.
20. +CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations. Blood 2009 Nov 5, 114(19):4138-4141.
21. Rosen-Wolff A., Soldan W., Heyne K., Bickhardt J., Gahr M., Roesler J. Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization. Ann Hematol 2001 Feb, 80(2):113-115.
22. Muthukumar T., Dadhania D., Ding R., Snopkowski C., Naqvi R., Lee J.B., et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005 Dec 1, 353(22):2342-2351.
23. Iwase H., Kobayashi T., Kodera Y., Miwa Y., Kuzuya T., Iwasaki K., et al. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation 2011 Jan 27, 91(2):191-198.
24. Bestard O., Cunetti L., Cruzado J.M., Lucia M., Valdez R., Olek S., et al. Intragraft regulatory t cells in protocol biopsies retain Foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant. 2011.
25. Bestard O., Cruzado J.M., Rama I., Torras J., Goma M., Seron D., et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008 Oct, 19(10):2020-2026.
26. Li Y., Zhao X., Cheng D., Haga H., Tsuruyama T., Wood K., et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008 Dec 27, 86(12):1837-1843.
27. Dijke I.E., Velthuis J.H., Caliskan K., Korevaar S.S., Maat A.P., Zondervan P.E., et al. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation 2007 Jun 15, 83(11):1477-1484.
28. Bunnag S., Allanach K., Jhangri G.S., Sis B., Einecke G., Mengel M., et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008 Jul, 8(7):1423-1433.
29. reg cells in renal transplants during acute cellular rejection episodes useful?. Clin Nephrol 2011, 75(2):101-106.
30. Thornton A.M., Piccirillo C.A., Shevach E.M. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 2004 Feb, 34(2):366-376.
31. Baan C.C., Peeters A.M., Demmers M.W., Mol W.M., Boer K., Samsom J.N., et al. FoxP3 T cells and the pathophysiologic effects of brain death and warm ischemia in donor kidneys. Clin J Am Soc Nephrol 2012 Sep, 7(9):1481-1489.
32. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001 Jan, 27(1):18-20.
33. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006 Jun, 116(6):1713-1722.
34. Zhang L., Zhang Y., Desrosiers M., Wang C., Zhao Y., Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Hum Immunol 2009 Nov, 70(11):930-934.
35. Fodor E., Garaczi E., Polyanka H., Koreck A., Kemeny L., Szell M. The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Hum Immunol 2011 Oct, 72(10):926-929.
36. Iwase K., Shimada A., Kawai T., Okubo Y., Kanazawa Y., Irie J., et al. FOXP3/Scurfin gene polymorphism is associated with adult onset type 1 diabetes in Japanese, especially in women and slowly progressive-type patients. Autoimmunity 2009 Feb, 42(2):159-167.
37. Lin Y.C., Lee J.H., Wu A.S., Tsai C.Y., Yu H.H., Wang L.C., et al. Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study. Lupus 2011 Feb, 20(2):137-143.
38. Gao L., Li K., Li F., Li H., Liu L., Wang L., et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci 2010 Jan, 57(1):51-56.
39. Zavattari P., Deidda E., Pitzalis M., Zoa B., Moi L., Lampis R., et al. No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes 2004 Jul, 53(7):1911-1914.
40. Nakanishi K., Shima Y. No contribution of a GT microsatellite polymorphism in the promoter region of the FOXP3 gene to susceptibility to type 1 diabetes in the Japanese population. Clin Chim Acta 2007 Sep, 384(1-2):171-173.
41. Greene C.S., Penrod N.M., Williams S.M., Moore J.H. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One 2009, 4(6):e5639.
42. Hirschhorn J.N., Altshuler D. Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 2002 Oct, 87(10):4438-4441.
43. Little J., Higgins J.P., Ioannidis J.P., Moher D., Gagnon F., von Elm E., et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 2009 Mar, 125(2):131-151.
44. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003 Mar 8, 361(9360):865-872.
45. Salomon D.R. Challenges to doing genetic association studies in transplantation. Am J Transplant 2012 Dec, 12(12):3173-3175.
46. Dijke I.E., Weimar W., Baan C.C. Regulatory T cells after organ transplantation: where does their action take place?. Hum Immunol 2008, 69(7):389-398.
47. Wood K.J., Bushell A., Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012 Jun, 12(6):417-430.